In the route of administration segment parenteral route of administration is expected to strengthen the growth of the clinical nutrition Market. The parenteral route of administration is the fastest route due to the absence of first-pass metabolism and direct administration of the drug into the bloodstream.
The Clinical Nutrition Market is projected to grow at a significant pace reaching a CAGR of approximately 7.1%, over the forecast period of 2022–2030, despite a considerable fall in Route of Administration sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
In a recent research report by Market Research Community, the clinical nutrition market is expected to surpass USD 62.29 billion by the year 2030, from USD 33.60 billion in 2021.
It is the discipline of medicine that assists patients in combating medical problems by implementing correct nutrition and a balanced, healthy diet. In other words, clinical nutrition comprises a nutritionist analyzing a patient's total nutrition to evaluate if they are getting enough nutrients in their daily diet.
The regional segment is separated into Asia Pacific, Europe, North America, the Middle East and Africa, and Latin America. North America is dominating the growth of the clinical nutrition market owing to the increasing prevalence of metabolic disorders and the increasing geriatric population. Further, Europe, Asia Pacific, the Middle East, and Africa, and Latin America are expected to support the growth of the clinical nutrition market.
The study is consolidated into major segments and further into sub-segments, such as by Patient Type (pediatric, adult, geriatric), Route of Administration (oral, parenteral, enteral) Application (cancer, malnutrition, neurological disease, gastrointestinal disorders, metabolic disorders, others) by end use (Research Academic Institutes, Pharmaceutical Biotechnology Companies, Diagnostic Laboratories, Other End Users) to forecast the size by value; also includes the analysis of past clinical nutrition market dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Abbott Laboratories,
Retrophin, Inc., QIAGEN N.V., Illumina Inc., PerkinElmer, Inc., BGI, Partek, Inc., Centogene A.G., Strand Life Sciences Pvt Ltd., Eurofins Scientific, Laboratory Corporation of America, Quest Diagnostics Inc., Invitae Corporation, 3billion, Inc., Arup Laboratories, Ambry Genetics, Macrogen, Inc., Baylor Genetics, Color Genomics, Inc., Health Network Laboratories.
Contact us:
Market Research Community
